Coronary artery diseases and particularly acute myocardial infarction are the leading causes
of mortality and morbidity in western countries. Despite the achievements of the last decades …

The no-reflow phenomenon has been studied extensively in the basic science laboratory
and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …

Impaired coronary flow after primary percutaneous coronary intervention (PPCI) is
associated with short-and long-term morbidity and mortality in patients with acute ST …

Takotsubo cardiomyopathy (TCM), characterized by reversible ventricular dysfunction, has
similar mortality to acute coronary syndrome. With the growing interest in the diagnosis of …

No-reflow is one of the major complications of primary percutaneous coronary artery
intervention (pPCI) in the treatment of acute ST-segment elevation myocardial infarction …

Background Impaired coronary artery reflow after primary percutaneous coronary
intervention (PPCI) in patients with ST‐segment elevation myocardial infarction has been …

Background Recently, it has been shown that the lymphocyte-to-monocyte ratio (LMR) is a
novel inflammatory marker. A decreased LMR is associated significantly with a high risk for …

Purpose It has been known that inflammatory mechanisms play an important role in the
coronary artery disease. Our aim in this study was to investigate the relationship between …

Purpose Hyperlipidemia (HLD) is one of the most common cardiovascular risk factors and is
prevalent in patients with takotsubo cardiomyopathy (TCM), but the association between …

We investigated whether admission estimated glomerular filtration rate (eGFR) values are
associated with no-reflow phenomenon in patients with ST-segment elevation myocardial …